Earlier diagnosis of bone and soft-tissue tumours

Journal of Bone and Joint Surgery - Series B

Volumn 92 B, Issue 11, 2010, Pages 1489-1492

  Grimer, R J ^a   Briggs, T W R ^b  

^a ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; EARLY DIAGNOSIS; OSTEOSARCOMA; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

ALGORITHMS; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; SOFT TISSUE NEOPLASMS;

EID: 78649404275     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B11.24326     Document Type: Review

References (27)

1. No authors listed. SEER Stat Fact Sheet. Cancer: soft tissue. National Cancer Insitute. http://seer.cancer.gov/statfacts/html/soft.html (date last accessed 9 July 2010).
2. No authors listed. NICE Guidance: improving outcomes for patients with sarcomas. 2006 http://guidance.nice.org.uk/csgsarcoma/guidance/pdf/English (date last accessed 9 July 2010).
3. No authors listed. NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma. Version 2.2010. http://www.nccn.org/professionals/physician-gls/ PDF/sarcoma.pdf (date last accessed 18 July 2010).
4. No authors listed. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer. Version 3.2010. http://www.nccn.org/professionals/physician-gls/PDF/ bone.pdf (date last accessed 18 July 2010).
5. Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY; ESMO Guidelines Working Group. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(Suppl 2):89-93.
6. No authors listed. VORTEX radiotherapy trial. http://www.vortex.bham.ac. uk/ (date last accessed 9 July 2010).
7. Paulussen M, Craft AW, Lewis I, European Intergroup Cooperative Ewing's Sarcoma Study-92. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment: cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008;26:4385-93.
8. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
9. Mendenhall WM, Indelicato DJ, Scarborough MT, et al. The management of adult soft tissue sarcomas. Am J Clin Oncol 2009;32:436-42.
10. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003;97:2530-43.
11. Grimer R. Size matters for sarcomas! Ann R Coll Surg Engl 2006;88:519-24. (Pubitemid 44596452)
12. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20:791-6.
13. Bramer JA, van Linge JH, Grimer RJ, Scholten RJ. Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol 2009;45:2367-75.
14. Hense HW, Ahrens S, Paulussen M, Lehnert M, Jurgens H. Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies. Ann Oncol 1999;10:1073-7.
15. Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg [Am] 1999;81-A:326-8.
16. Fiorenza F, Abudu A, Grimer RJ, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg [Br] 2002;84-B:93-9.
17. Grimer RJ, Sneath RS. Diagnosing malignant bone tumours. J Bone Joint Surg [Br] 1990;72-B:754-6.
18. Johnson GD, Smith G, Dramis A, Grimer RJ. Delays in referral of soft tissue sarcomas. Sarcoma 2008;2008:378574.
19. Ashwood B, Witt JD, Hallam PJ, Cobb JP. Analysis of the referral pattern to a supraregional bone and soft tissue tumour service. Ann R Coll Surg Engl 2003;85:272-6.
20. No authors listed. Referral Guidelines for Suspected Cancer http://www.dh.gov.uk/assetRoot/04/01/44/21/04014421.pdf (date last accessed 9 July 2010).
21. No authors listed. Referral Guidelines for Suspected Cancer 2005 http://guidance. nice.org.uk/CG27/Guidance/pdf/English (date last accessed 9 July 2010).
22. Mannan K, Briggs TW. Soft tissue tumours of the extremities. BMJ 2005;331:590.
23. Malik A, Wigney MA, Murray S, Gerrand CH. The effectiveness of "two week" referrals for suspected bone and softtissue sarcoma. Sarcoma 2007; 2007:23870.
24. Bauer HC, Trovik CS, Alvegård TA, et al. Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001;72:150-9.
25. Chandrasekar CR, Wafa H, Grimer RJ, et al. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg [Br] 2008;90-B:203-8. (Pubitemid 351303348)
26. Tillman RM. The role of the orthopaedic surgeon in metastatic disease of the appendicular skeleton. J Bone Joint Surg [Br] 1999;81-B:1-2.
27. Al-Hakim WI, Jagiello JM, Briggs TW. The palliative role of orthopaedics. BMJ 2006;332:1227-8.